Thu, Dec 19, 2024
Volume 10, Issue 1 (6-2021)
ABS 2021, 10(1): 15-20 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hatami M, Ansar H, Khajavi S, Mohammadi-Farsani G. The Potential Role of Fish Oil/Omega-3 Polyunsaturated Fatty Acids Supplementation on Liver Size Before Bariatric Surgery. ABS 2021; 10 (1) :15-20
URL: http://annbsurg.iums.ac.ir/article-1-313-en.html
URL: http://annbsurg.iums.ac.ir/article-1-313-en.html
1- Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran. Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.
2- Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Seafood Processing, Tarbiat Modarres University, Tehran, Iran.
2- Minimally Invasive Surgery Research Center, Iran University of Medical Sciences, Tehran, Iran.
3- Department of Seafood Processing, Tarbiat Modarres University, Tehran, Iran.
Abstract: (964 Views)
Background: An enlarged liver, which is resulted from fatty liver and/or steatohepatitis, makes difficulties in gastric bypass surgery procedure and increases the risk of liver laceration. omega-3 polyunsaturated fatty acids (ω-3 PUFAs) recently have been suggested as a potential intervention to reduce liver inflammation and volume. This review aimed to provide a comprehensive overview of the recent advances on fish oil/ ω-3 PUFAs supplementation to reduce the liver volume proceeding to bariatric surgery.
Methods: This review summarizes studies that were investigated the influence of fish oil/omega-3 PUFA in the liver volume of bariatric surgery candidates. Scopus and PubMed databases were systematically searched up to May 2021, for studies providing knowledge relating to the effects of omega-3 and/or fish oil supplementation on liver size, fatty liver, or steatohepatitis.
Results: Most of the randomized controlled trials showed that ω-3 PUFA supplementation, mostly due to its anti-inflammatory and antioxidative properties, is a practical and effective treatment for fatty liver, and to decrease ALT, AST, and GGT. Omega-3 fatty acids as important regulators of hepatic gene transcription can reduce hepatic steatosis and inflammation markers, also improve insulin sensitivity. As well, the access to the gastroesophageal junction was reported as simple.
Conclusion: The collective data suggest that preoperative fish oil ω-3 PUFA supplementation could be an effective approach in improving liver function and decrease liver volume before bariatric surgery. Although, well-designed randomized clinical trials are needed to confirm these results and determine a clear protocol of supplementation regarding the optimal dose and duration before surgery.
Methods: This review summarizes studies that were investigated the influence of fish oil/omega-3 PUFA in the liver volume of bariatric surgery candidates. Scopus and PubMed databases were systematically searched up to May 2021, for studies providing knowledge relating to the effects of omega-3 and/or fish oil supplementation on liver size, fatty liver, or steatohepatitis.
Results: Most of the randomized controlled trials showed that ω-3 PUFA supplementation, mostly due to its anti-inflammatory and antioxidative properties, is a practical and effective treatment for fatty liver, and to decrease ALT, AST, and GGT. Omega-3 fatty acids as important regulators of hepatic gene transcription can reduce hepatic steatosis and inflammation markers, also improve insulin sensitivity. As well, the access to the gastroesophageal junction was reported as simple.
Conclusion: The collective data suggest that preoperative fish oil ω-3 PUFA supplementation could be an effective approach in improving liver function and decrease liver volume before bariatric surgery. Although, well-designed randomized clinical trials are needed to confirm these results and determine a clear protocol of supplementation regarding the optimal dose and duration before surgery.
Keywords: Fish Oil, Omega-3 Fatty Acids, Polyunsaturated Fatty Acids, Liver Size, Fatty Liver, Bariatric Surgery, Morbid Obesity.
Type of Study: Review/Systematic Review |
Subject:
Bariatric Surgery
Received: 2021/04/10 | Accepted: 2021/05/20 | ePublished: 2021/11/10
Received: 2021/04/10 | Accepted: 2021/05/20 | ePublished: 2021/11/10
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
